Gujarat Inject (Kerala) Ltd
Gujarat Inject (Kerala) Ltd has discontinued
its legacy pharmaceutical manufacturing operations and currently follows a trading
-led business model transitioning towards renewable energy. Its disclosed activities
include supplying 600–620Wp solar-PV modules, investing in a 5MW solar project
and evaluating thermal-energy-storage opportunities.[1] [2] [3]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Directors on the Board count |
|
||||||||||
| Number of Board Meetings Held count |
|||||||||||
| Number of Permanent Employees count |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Issue Of Shares Via Preferential Issue.
- Board meeting rescheduled to 29 Oct 2026 to consider preferential allotment of equity shares and warrants.
-
Board Meeting Intimation for Issue Of Shares Via Preferential Issue
- Board to meet on 26 Oct 2026 to consider preferential allotment of equity shares and warrants.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Won ₹6.25 crore order from Deon Energy for 8,065 solar modules, to complete by October 2026.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
- Received order from DEON Energy for 8,065 solar panels worth about 6.25 crore, to execute by October 2026.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Company reports ₹4.86 crore solar order, ₹20.76 crore CWIP, and FY26 revenue rose to ₹36.32 crore.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2011
from bse
-
Annual Report 2007
from bse
-
Annual Report 2005
from bse
Name Change:[1]
Shareholders approved changing the company’s name to Regenova Renewtech Ltd on August 19th, 2026.